FDA Panel Rejects Vivus’ Obesity Drug

The Endocrinologic and Metabolic Drugs Advisory Committee of the US Food and Drug Administration (FDA) voted against recommending approval of Vivus’ obesity drug, Qnexa. The panel voted 10–6 against recommending approval of the dru

Obama Bypasses Senate, Names Controversial CMS Chief

Employing a tool as old as the presidency itself, President Barack Obama has named Donald M. Berwick, MD, MPP, a Harvard professor and patient care specialist, in a recess appointment as chief of the Centers for Medicare and Medicaid Services.

Mark R. Rosekind Sworn In as NTSB Member

Mark R. Rosekind, PhD, took the oath of office as a member of the National Transportation Safety Board. Rosekind is an internationally recognized fatigue expert who has conducted research and implemented programs in diverse settings, includin